<ARTICLE> 5 <RESTATED> <MULTIPLIER> 1,000 <PERIOD-TYPE> 9-MOS <FISCAL-YEAR-END> DEC-31-1997 <PERIOD-END> SEP-30-1997 <CASH> 1,504,144 <SECURITIES> 36,775 <RECEIVABLES> 1,641,117 <ALLOWANCES> 61,444 <INVENTORY> 914,719 <CURRENT-ASSETS> 4,609,102 <PP&E> 7,023,242 <DEPRECIATION> 2,928,055 <TOTAL-ASSETS> 11,819,157 <CURRENT-LIABILITIES> 3,647,031 <BONDS> 2,343,798 <PREFERRED-MANDATORY> 0 <PREFERRED> 0 <COMMON> 702,020 <OTHER-SE> 3,688,873 <TOTAL-LIABILITY-AND-EQUITY> 11,819,157 <SALES> 5,783,936 <TOTAL-REVENUES> 6,101,770 <CGS> 1,442,998 <TOTAL-COSTS> 1,677,886 <OTHER-EXPENSES> 5,047,876<F18> <LOSS-PROVISION> 0<F19> <INTEREST-EXPENSE> 180,432 <INCOME-PRETAX> (99,841) <INCOME-TAX> 742,722 <INCOME-CONTINUING> (842,563) <DISCONTINUED> 0 <EXTRAORDINARY> 0 <CHANGES> 0 <NET-INCOME> (842,563) <EPS-PRIMARY> (.77) <EPS-DILUTED> (.79) <FN> <F18>-Amounts include research and development, selling and general and administrative expenses, and asset impairment. <F19>-The information called for is not given as the balances are not individually significant. </FN>